首页> 美国卫生研究院文献>Scientific Reports >A fragment-based approach applied to a highly flexible target: Insights and challenges towards the inhibition of HSP70 isoforms
【2h】

A fragment-based approach applied to a highly flexible target: Insights and challenges towards the inhibition of HSP70 isoforms

机译:基于片段的方法适用于高度灵活的靶标:抑制HSP70亚型的见解和挑战

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The heat shock protein 70s (HSP70s) are molecular chaperones implicated in many cancers and of significant interest as targets for novel cancer therapies. Several HSP70 inhibitors have been reported, but because the majority have poor physicochemical properties and for many the exact mode of action is poorly understood, more detailed mechanistic and structural insight into ligand-binding to HSP70s is urgently needed. Here we describe the first comprehensive fragment-based inhibitor exploration of an HSP70 enzyme, which yielded an amino-quinazoline fragment that was elaborated to a novel ATP binding site ligand with different physicochemical properties to known adenosine-based HSP70 inhibitors. Crystal structures of amino-quinazoline ligands bound to the different conformational states of the HSP70 nucleotide binding domain highlighted the challenges of a fragment-based approach when applied to this particular flexible enzyme class with an ATP-binding site that changes shape and size during its catalytic cycle. In these studies we showed that Ser275 is a key residue in the selective binding of ATP. Additionally, the structural data revealed a potential functional role for the ATP ribose moiety in priming the protein for the formation of the ATP-bound pre-hydrolysis complex by influencing the conformation of one of the phosphate binding loops.
机译:热休克蛋白70s(HSP70s)是与许多癌症有关的分子伴侣,作为新型癌症治疗的靶标具有重要的意义。已经报道了几种HSP70抑制剂,但是由于大多数具有较差的理化性质,并且对于许多确切的作用方式还知之甚少,因此迫切需要对配体与HSP70s结合的机制和结构进行更深入的了解。在这里,我们描述了HSP70酶的首次基于片段的全面抑制剂研究,该酶产生了一个氨基喹唑啉片段,该片段被修饰成具有与已知的基于腺苷的HSP70抑制剂不同的理化性质的新型ATP结合位点配体。与HSP70核苷酸结合结构域的不同构象状态结合的氨基喹唑啉配体的晶体结构突出显示了基于片段的方法的挑战,该方法应用于具有ATP结合位点的特殊柔性酶类时,在催化过程中会改变形状和大小周期。在这些研究中,我们表明Ser275是ATP选择性结合的关键残基。另外,结构数据显示,通过影响磷酸结合环之一的构象,ATP核糖部分在引发蛋白质形成ATP结合的预水解复合物方面具有潜在的功能作用。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号